These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome. Songu M, Unlu HH, Gunhan K, Ilker SS, Nese N. Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868 [Abstract] [Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. Thomas PA, Geraldine P. Indian J Ophthalmol; 2004 Jun; 52(2):171-2; author reply 172. PubMed ID: 15283230 [No Abstract] [Full Text] [Related]
6. Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracraneal affection and improve survival. Plowes Hernández O, Prado Calleros HM, Soberón Marmissolle Daguerre GS, Sadek González A. Acta Otorrinolaringol Esp; 2015 Jun; 66(6):348-52. PubMed ID: 26048708 [Abstract] [Full Text] [Related]
7. Use of radiopaque intraorbital catheter in the treatment of sino-orbito-cranial mucormycosis. Kahana A, Lucarelli MJ. Arch Ophthalmol; 2007 Dec; 125(12):1714-5. PubMed ID: 18071129 [No Abstract] [Full Text] [Related]
8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A, Mathialagan A, Aishwarya A, Ravisankar, Bhuskute G, Kanaujia V, Singh AK, Singh RK, Dhiman RK, Agarwal R. Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [Abstract] [Full Text] [Related]
11. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A, Ramadhin AK, Tripathi AK, Gupta A, Bhargava A, Sahu A, Khairnar A, Kochar A, Madhavani A, Shrivastava AK, Desai AK, Paul A, Ayyar A, Bhatnagar A, Singhal A, Nikose AS, Bhargava A, Tenagi AL, Kamble A, Nariani A, Patel B, Kashyap B, Dhawan B, Vohra B, Mandke C, Thrishulamurthy C, Sambare C, Sarkar D, Mankad DS, Maheshwari D, Lalwani D, Kanani D, Patel D, Manjandavida FP, Godhani F, Agarwal GA, Ravulaparthi G, Shilpa GV, Deshpande G, Thakkar H, Shah H, Ojha HR, Jani H, Gontia J, Mishrikotkar JP, Likhari K, Prajapati K, Porwal K, Koka K, Dharawat KS, Ramamurthy LB, Bhattacharyya M, Saini M, Christy MC, Das M, Hada M, Panchal M, Pandharpurkar M, Ali MO, Porwal M, Gangashetappa N, Mehrotra N, Bijlani N, Gajendragadkar N, Nagarkar NM, Modi P, Rewri P, Sao P, Patil PS, Giri P, Kapadia P, Yadav P, Bhagat P, Parekh R, Dyaberi R, Chauhan RS, Kaur R, Duvesh RK, Murthy R, Dandu RV, Kathiara R, Beri R, Pandit R, Rani RH, Gupta R, Pherwani R, Sapkal R, Mehta R, Tadepalli S, Fatima S, Karmarkar S, Patil SS, Shah S, Shah S, Shah S, Dubey S, Gandhi S, Kanakpur S, Mohan S, Bhomaj S, Kerkar S, Jariwala S, Sahu S, Tara S, Maru SK, Jhavar S, Sharma S, Gupta S, Kumari S, Das S, Menon S, Burkule S, Nisar SP, Kaliaperumal S, Rao S, Pakrasi S, Rathod S, Biradar SG, Kumar S, Dutt S, Bansal S, Ravani SA, Lohiya S, Ali Rizvi SW, Gokhale T, Lahane TP, Vukkadala T, Grover T, Bhesaniya T, Chawla U, Singh U, Une VL, Nandedkar V, Subramaniam V, Eswaran V, Chaudhry VN, Rangarajan V, Dehane V, Sahasrabudhe VM, Sowjanya Y, Tupkary Y, Phadke Y, members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group. Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [Abstract] [Full Text] [Related]
12. Mucormycosis: early treatment is the key to survival. Holmes TR, Hepschke JL, Jacobson I, Maloof A. Med J Aust; 2021 Nov 01; 215(9):401-403. PubMed ID: 34628643 [No Abstract] [Full Text] [Related]
13. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Br J Ophthalmol; 2019 Oct 01; 103(10):1460-1465. PubMed ID: 30514712 [Abstract] [Full Text] [Related]
14. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Thajeb P, Thajeb T, Dai D. Scand J Infect Dis; 2004 Oct 01; 36(9):643-8. PubMed ID: 15370650 [Abstract] [Full Text] [Related]
15. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Nair AG, Dave TV. Orbit; 2022 Jun 01; 41(3):275-286. PubMed ID: 34720026 [Abstract] [Full Text] [Related]
16. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, Chakarbarti A, Dash RJ. Postgrad Med J; 2004 Nov 01; 80(949):670-4. PubMed ID: 15537854 [Abstract] [Full Text] [Related]
17. Mucormycosis presenting with painful ophthalmoplegia. Karakurum B, Karatas M, Cagici AC, Uncu H, Yildirim T, Hurcan C, Karaca S, Kizilkilic E, Tan M. Acta Neurol Belg; 2005 Dec 01; 105(4):201-5. PubMed ID: 16482869 [Abstract] [Full Text] [Related]
18. Serous retinal detachment in a patient with rhino-orbital mucormycosis. Kim IT, Shim JY, Jung BY. Jpn J Ophthalmol; 2001 Dec 01; 45(3):301-4. PubMed ID: 11369382 [Abstract] [Full Text] [Related]
20. CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From a Single Center in India. Joshi AR, Muthe MM, Patankar SH, Athawale A, Achhapalia Y. AJR Am J Roentgenol; 2021 Dec 01; 217(6):1431-1432. PubMed ID: 34161127 [Abstract] [Full Text] [Related] Page: [Next] [New Search]